Estée Lauder Cos. has received final bids for three of its prestige beauty brands: Smashbox, Too Faced, and Dr. Jart. The sale process unfolds as Puig, the Spanish fragrance and fashion conglomerate, continues merger negotiations with Estée Lauder itself.
The divestiture of these three brands signals Estée Lauder's strategic reshuffling under pressure to streamline operations and improve financial performance. Smashbox, known for its color cosmetics and particularly its primers, joins Too Faced, the playful makeup label famous for its chocolate-scented bronzers and eyeshadow palettes, and Dr. Jart, the Korean skincare powerhouse recognized for its Ceramidin and Cicapair lines, on the auction block.
Puig already owns significant beauty assets including Saint Laurent Beauty, Carolina Herrera Beauty, and Prada Beauty. A merger between Puig and Estée Lauder would create a formidable player in global prestige beauty, combining Estée Lauder's portfolio of heritage brands like MAC, Clinique, and Bobbi Brown with Puig's luxury fragrance and fashion credentials. However, such a combination would likely trigger regulatory scrutiny over market concentration, particularly in prestige makeup and skincare.
The timing reflects broader industry consolidation as mega-corporations seek to absorb smaller brands and maximize portfolio efficiency. For Estée Lauder, divesting these three labels could unlock billions in cash while allowing the company to focus on its core brands and strengthen its balance sheet ahead of potential merger completion.
Buyers for these brands will likely come from existing beauty conglomerates, private equity firms, or ambitious indie beauty companies looking to scale. Each brand commands distinct value. Dr. Jart brings the fastest-growing skin